相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment
Traian Sulea et al.
MABS (2020)
Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains
Greg Hussack et al.
PLoS One (2018)
Half-life extension using serum albumin-binding DARPin (R) domains
Daniel Steiner et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2017)
Fc-fusion Proteins in Therapy: An Updated View
Reza Jafari et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Single-chain antibody-fragment M6P-1 possesses a mannose 6-phosphate monosaccharide-specific binding pocket that distinguishes N-glycan phosphorylation in a branch-specific manner
Ryan J. Blackler et al.
GLYCOBIOLOGY (2016)
Half-life extended biotherapeutics
Roland E. Kontermann
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers
Vladimir N. Podust et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding
Emma Dave et al.
MABS (2016)
Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin Fv domain: An investigation into the correlation between affinity and serum half-life
Ralph Adams et al.
MABS (2016)
Isolation of a pH-Sensitive IgNAR Variable Domain from a Yeast-Displayed, Histidine-Doped Master Library
Doreen Koenning et al.
MARINE BIOTECHNOLOGY (2016)
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
William R. Strohl
BIODRUGS (2015)
What is the future of PEGylated therapies?
Magdalena Swierczewska et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
De novo isolation of antibodies with pH-dependent binding properties
Pauline Bonvin et al.
MABS (2015)
Identification of cross-reactive single-domain antibodies against serum albumin using next-generation DNA sequencing
Kevin A. Henry et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2015)
A generic approach to engineer antibody pH-switches using combinatorial histidine scanning libraries and yeast display
Christian Schroeter et al.
MABS (2015)
A novel platform for engineering blood-brain barrier-crossing bispecific biologics
Graham K. Farrington et al.
FASEB JOURNAL (2014)
Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile
Tomohiko Murase et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
Samir Mitragotri et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The intrinsic cysteine and histidine residues of the anti-Salmonella antibody Se155-4: a model for the introduction of new functions into antibody-binding sites
N. Martin Young et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Albumin as a versatile platform for drug half-life extension
Darrell Sleep et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
Martin Schlapschy et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface
Michael M. Schmidt et al.
STRUCTURE (2013)
THE ALBUMIN-BINDING DOMAIN AS A SCAFFOLD FOR PROTEIN ENGINEERING
Johan Nilvebrant et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2013)
Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9
Javier Chaparro-Riggers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain
Mischa R. Mueller et al.
MABS (2012)
Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor
Jan Terje Andersen et al.
NATURE COMMUNICATIONS (2012)
Neutralization of Clostridium difficile Toxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain
Greg Hussack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Analysis and Modeling of the Variable Region of Camelid Single-Domain Antibodies
Aroop Sircar et al.
JOURNAL OF IMMUNOLOGY (2011)
High Affinity Antigen Recognition of the Dual Specific Variants of Herceptin Is Entropy-Driven in Spite of Structural Plasticity
Jenny Bostrom et al.
PLOS ONE (2011)
Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability
Greg Hussack et al.
PLOS ONE (2011)
A Combinatorial Histidine Scanning Library Approach to Engineer Highly pH-Dependent Protein Switches
Megan L. Murtaugh et al.
PROTEIN SCIENCE (2011)
Glycosylation of Therapeutic Proteins An Effective Strategy to Optimize Efficacy
Ricardo J. Sola et al.
BIODRUGS (2010)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
Tomoyuki Igawa et al.
NATURE BIOTECHNOLOGY (2010)
Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon
Adam Walker et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
Lucy J. Holt et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin
Allen Nguyen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
Formatted anti-tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis
Ken Coppieters et al.
ARTHRITIS AND RHEUMATISM (2006)
Albumin binding as a general strategy for improving the pharmacokinetics of proteins
MS Dennis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
K Katoh et al.
NUCLEIC ACIDS RESEARCH (2002)
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells
Y Durocher et al.
NUCLEIC ACIDS RESEARCH (2002)
Prolonged in vivo residence times of antibody fragments associated with albumin
BJ Smith et al.
BIOCONJUGATE CHEMISTRY (2001)
Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides
A Knappik et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
分享论文
